Join to access to all OVN content. Join for Free
OncologyVoiceNetwork RaminFarhood KirkShepard OVNLeadership PharmaVoice100 CancerInnovation OncologyExperts MedicalAffairs OncologyStrategy HealthcareLeadership BiotechExecutives CancerCare PharmaExecutives DigitalOncology LifeSciencesLeader

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard


At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving this mission are two trailblazers who have spent decades shaping the future of medical innovation—Dr. Ramin Farhood and Dr. Kirk Shepard.

Together, they bring unmatched expertise, global leadership, and a shared passion for breaking down barriers in oncology communication and collaboration.

Dr. Ramin Farhood, PharmD

Chief Executive Officer, OVN

Dr. Ramin Farhood is a distinguished pharmacologist and accomplished senior medical executive with over 20 years of global leadership in medical affairs. Known for his deep commitment to elevating the role of medical professionals within life sciences, Dr. Farhood has co-founded two key institutions that continue to shape the industry: the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS).

Throughout his career, he has held multiple high-impact roles in top pharmaceutical companies, steering strategic initiatives across global markets. His visionary thinking and ability to connect science with purpose earned him a coveted spot on Phar

maVoice’s 100 Most Inspiring People in the Pharmaceutical Industry—a testament to his impact and leadership.

At OVN, Dr. Farhood leads with a clear goal: to build a platform where expertise, insight, and innovation converge to drive meaningful progress in oncology care.


Share This Article

Oncology Voice Network founders, Ramin Farhood PharmD, Kirk Shepard MD, OVN leadership team, oncology innovation leaders, pharma thought leadership, oncology network co-founders, medical affairs experts, oncology digital platform, oncology collaboration p

Related Topics

Loading...